394
Views
24
CrossRef citations to date
0
Altmetric
Drug Evaluations

Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety

, MRCP, , FRCPath, , MD, , MSc, , MD, , MD & , MD show all
Pages 1345-1362 | Published online: 21 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Michael France. (2014) The withdrawal of the thyromimetic eprotirome. Clinical Lipidology 9:5, pages 483-486.
Read now
Michael France, Jonathan Schofield, See Kwok & Handrean Soran. (2014) Treatment of homozygous familial hypercholesterolemia. Clinical Lipidology 9:1, pages 101-118.
Read now
Atul Ashok Kalanuria, Paul Nyquist & Geoffrey Ling. (2012) The prevention and regression of atherosclerotic plaques: emerging treatments. Vascular Health and Risk Management 8, pages 549-561.
Read now
Mario Cozzolino, Elena Bruschetta, Daniele Cusi, Emanuele Montanari, Maria Enrica Giovenzana & Andrea Galassi. (2012) Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate. Expert Opinion on Pharmacotherapy 13:16, pages 2337-2353.
Read now

Articles from other publishers (20)

Erik T. Diniz, Ana Carolina S. M. Cardoso & Francisco Bandeira. 2022. Endocrinology and Diabetes. Endocrinology and Diabetes 461 472 .
Karen Alejandra Méndez-Lara, David Santos, Núria Farré, Madalina Nicoleta Nan, Víctor Pallarès, Antonio Pérez-Pérez, Núria Alonso, Joan Carles Escolà-Gil, Francisco Blanco-Vaca & Josep Julve. (2019) Vitamin B3 impairs reverse cholesterol transport in Apolipoprotein E-deficient mice. Clínica e Investigación en Arteriosclerosis 31:6, pages 251-260.
Crossref
Karen Alejandra Méndez-Lara, David Santos, Núria Farré, Madalina Nicoleta Nan, Víctor Pallarès, Antonio Pérez-Pérez, Núria Alonso, Joan Carles Escolà-Gil, Francisco Blanco-Vaca & Josep Julve. (2019) Vitamin B3 impairs reverse cholesterol transport in Apolipoprotein E-deficient mice. Clínica e Investigación en Arteriosclerosis (English Edition) 31:6, pages 251-260.
Crossref
Maria Guarino & Jean-François Dufour. (2019) Nicotinamide and NAFLD: Is There Nothing New Under the Sun?. Metabolites 9:9, pages 180.
Crossref
Amir Abbas Momtazi‐Borojeni, Niki Katsiki, Matteo Pirro, Maciej Banach, Khalid Al Rasadi & Amirhossein Sahebkar. (2019) Dietary natural products as emerging lipoprotein(a)‐lowering agents. Journal of Cellular Physiology 234:8, pages 12581-12594.
Crossref
Gaber Moustafa, Hemat Khalaf, Ahmed Naglah, Asma Al-Wasidi, Nawal Al-Jafshar & Hassan Awad. (2018) Synthesis, Molecular Docking Studies, In Vitro Antimicrobial and Antifungal Activities of Novel Dipeptide Derivatives Based on N-(2-(2-Hydrazinyl-2-oxoethylamino)-2-oxoethyl)-Nicotinamide. Molecules 23:4, pages 761.
Crossref
Regina Appiah-Opong, Isaac Tuffour, Ebenezer Ofori-Attah, Abigail Aning, Philip Atchoglo, Eunice Ampem Danso, Believe Ahedor, Samuel Adjei & Alexander K. Nyarko. (2018) In Vivo Modulation of Rat Liver Microsomal Cytochrome P450 Activity by Antimalarial, Anti-HIV, and Antituberculosis Plant Medicines. Journal of Evidence-Based Integrative Medicine 23, pages 2515690X1881000.
Crossref
Stefan Offermanns. (2017) Hydroxy-Carboxylic Acid Receptor Actions in Metabolism. Trends in Endocrinology & Metabolism 28:3, pages 227-236.
Crossref
Amutha Iswarya Devi Jeyaraman & Kottai Muthu Arumugam. (2015) Hypolipidemic effect of ethanolic extract from whole plant of Lactuca runcinata (DC.) in atherogenic diet induced hyperlipidemic rats. African Journal of Pharmacy and Pharmacology 9:47, pages 1080-1087.
Crossref
Ulrich Julius. (2015) Niacin as antidyslipidemic drug. Canadian Journal of Physiology and Pharmacology 93:12, pages 1043-1054.
Crossref
Rahul Yadav, Yifen Liu, See Kwok, Salam Hama, Michael France, Ruth Eatough, Phil Pemberton, Jonathan Schofield, Tarza J. Siahmansur, Rayaz Malik, Basil A. Ammori, Basil Issa, Naveed Younis, Rachelle Donn, Adam Stevens, Paul Durrington & Handrean Soran. (2015) Effect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients. Journal of the American Heart Association 4:9.
Crossref
Dustin L. Cooper, Derek E. Murrell, David S. Roane & Sam Harirforoosh. (2015) Effects of formulation design on niacin therapeutics: mechanism of action, metabolism, and drug delivery. International Journal of Pharmaceutics 490:1-2, pages 55-64.
Crossref
Miao Hu, Ya-Ling Yang, Daisaku Masuda, Shizuya Yamashita & Brian Tomlinson. (2015) Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia. Disease Markers 2015, pages 1-8.
Crossref
Nujarin Sinthupoom, Veda Prachayasittikul, Supaluk Prachayasittikul, Somsak Ruchirawat & Virapong Prachayasittikul. (2014) Nicotinic acid and derivatives as multifunctional pharmacophores for medical applications. European Food Research and Technology 240:1, pages 1-17.
Crossref
Monica Gomaraschi, Maria Pia Adorni, Maciej Banach, Franco Bernini, Guido Franceschini & Laura Calabresi. 2015. High Density Lipoproteins. High Density Lipoproteins 593 615 .
Paul N. Durrington, Jonathan D. Schofield, Tarza Siahmansur & Handrean Soran. (2014) Lipoprotein (a). Current Opinion in Lipidology 25:4, pages 289-296.
Crossref
Esfandiar Heidarian, Mahmoud Rafieian-Kopaei, Abolfazle Khoshdel & Morteza Bakhshesh. (2014) Metabolic effects of berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: an additional mechanism for the hypolipidemic effects of berberine. Asian Pacific Journal of Tropical Biomedicine 4, pages S429-S435.
Crossref
Erik T. Diniz & Francisco Bandeira. 2014. Endocrinology and Diabetes. Endocrinology and Diabetes 489 502 .
U. Julius & S. Fischer. (2013) Nicotinic acid as a lipid-modifying drug – A review. Atherosclerosis Supplements 14:1, pages 7-13.
Crossref
Rigotti R. Attilio. (2012) Actualización en el manejo del colesterol hdl bajo. Revista Médica Clínica Las Condes 23:6, pages 689-692.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.